Literature DB >> 16980909

Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda.

Miguel A Arroyo1, Warren B Sateren, David Serwadda, Ronald H Gray, Maria J Wawer, Nelson K Sewankambo, Noah Kiwanuka, Godfrey Kigozi, Fred Wabwire-Mangen, Michael Eller, Leigh Anne Eller, Deborah L Birx, Merlin L Robb, Francine E McCutchan.   

Abstract

OBJECTIVE: To determine the association between the incidence of HIV-1 infection and the genetic complexity of HIV-1 strains in 2 geographic strata within Rakai District, Uganda.
METHODS: Study volunteers with recent HIV-1 infections during the period 1997 through 2003 were recruited from 10 communities that were geographically stratified as a main road trading center (n = 5) or a secondary road trading village (n = 5). Cryopreserved plasma was available from 384 volunteers and was the source of viral RNA for genotyping by the multiregion hybridization assay. Hazard ratios (HRs) for a single HIV subtype, a recombinant form, or dual infection for gender and geographic strata were obtained using Cox proportional hazards analysis.
RESULTS: The HIV-1 incidence rate during the period 1999 through 2002 was 1.3 per 100 person-years (PYs) in the trading centers and 1.1 per 100 PYs in the trading villages. The HR for infection with an HIV-1 recombinant strain in trading centers relative to trading villages was 2.3 (95% confidence interval [CI]: 1.0 to 6.7). Among those who changed residence between village strata, the HR for a recombinant HIV-1 infection was 8.1 (95% CI: 0.4 to 47.7).
CONCLUSIONS: HIV-1 incidence and genetic complexity are associated with geographic strata and population mobility in Rakai District and are important variables to be considered in planning and recruitment for vaccine trials.

Entities:  

Mesh:

Year:  2006        PMID: 16980909     DOI: 10.1097/01.qai.0000243053.80945.f0

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  26 in total

1.  Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002.

Authors:  Samantha A Conroy; Oliver Laeyendecker; Andrew D Redd; Aleisha Collinson-Streng; Xiangrong Kong; Fredrick Makumbi; Tom Lutalo; Nelson Sewankambo; Noah Kiwanuka; Ronald H Gray; Maria J Wawer; David Serwadda; Thomas C Quinn
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-06       Impact factor: 2.205

2.  Relating diarrheal disease to social networks and the geographic configuration of communities in rural Ecuador.

Authors:  Sarah J Bates; James Trostle; William T Cevallos; Alan Hubbard; Joseph N S Eisenberg
Journal:  Am J Epidemiol       Date:  2007-08-09       Impact factor: 4.897

Review 3.  T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces.

Authors:  Bette T Korber; Norman L Letvin; Barton F Haynes
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

4.  A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys.

Authors:  Sampa Santra; Bette T Korber; Mark Muldoon; Dan H Barouch; Gary J Nabel; Feng Gao; Beatrice H Hahn; Barton F Haynes; Norman L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

5.  Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Chirapa Eamsila; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Chawetsan Namwat; Nakorn Premsri; Michael Benenson; Patricia Morgan; Meera Bose; Eric Sanders-Buell; Robert Paris; Merlin L Robb; Deborah L Birx; Mark S De Souza; Francine E McCutchan; Nelson L Michael; Jerome H Kim
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

6.  HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels.

Authors:  Michael A Eller; Marc S Opollo; Michelle Liu; Andrew D Redd; Leigh Anne Eller; Cissy Kityo; Joshua Kayiwa; Oliver Laeyendecker; Maria J Wawer; Mark Milazzo; Noah Kiwanuka; Ronald H Gray; David Serwadda; Nelson K Sewankambo; Thomas C Quinn; Nelson L Michael; Fred Wabwire-Mangen; Johan K Sandberg; Merlin L Robb
Journal:  J Infect Dis       Date:  2014-11-17       Impact factor: 5.226

7.  Spatial and socio-behavioral patterns of HIV prevalence in the Democratic Republic of Congo.

Authors:  Jane P Messina; Michael Emch; Jeremie Muwonga; Kashamuka Mwandagalirwa; Samuel B Edidi; Nicaise Mama; Augustin Okenge; Steven R Meshnick
Journal:  Soc Sci Med       Date:  2010-08-05       Impact factor: 4.634

8.  High-throughput high-resolution class I HLA genotyping in East Africa.

Authors:  Rebecca N Koehler; Anne M Walsh; Eric E Sanders-Buell; Leigh Anne Eller; Michael Eller; Jeffrey R Currier; Christian T Bautista; Fred Wabwire-Mangen; Michael Hoelscher; Leonard Maboko; Jerome Kim; Nelson L Michael; Merlin L Robb; Francine E McCutchan; Gustavo H Kijak
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

9.  Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda.

Authors:  Susan H Eshleman; Oliver Laeyendecker; Neil Parkin; Wei Huang; Colombe Chappey; Agnes C Paquet; David Serwadda; Steven J Reynolds; Noah Kiwanuka; Thomas C Quinn; Ronald Gray; Maria Wawer
Journal:  AIDS       Date:  2009-04-27       Impact factor: 4.177

10.  Relatively low HIV infection rates in rural Uganda, but with high potential for a rise: a cohort study in Kayunga District, Uganda.

Authors:  David Guwatudde; Fred Wabwire-Mangen; Leigh Anne Eller; Michael Eller; Francine McCutchan; Hannah Kibuuka; Monica Millard; Nelson Sewankambo; David Serwadda; Nelson Michael; Merlin Robb
Journal:  PLoS One       Date:  2009-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.